A New Jersey-based drug manufacturer has issued a retail and pharmacy-level drug recall for 65 different drugs after the manufacturing facility failed a Food and Drug Administration (FDA) inspection.

The inspection at the Little Falls, N.J., facility of Actavis Totowa LLC did not meet the FDA's or Actavis' standards for good manufacturing practices, the company said in a statement. However, consumers are not being asked to return the drugs and should continue their medications until told otherwise by a doctor.

The company also added that the risk of suddenly stopping the needed medication before obtaining replacement drugs may place patients at risk. Drugs affected by the recall include pain killers, antidepressants, diet medication and other drugs for blood pressure and hypertension.

Pharmaceuticals manufactured at other Actavis sites are not impacted by this recall, the company said.